FDA Drops Suicide Warnings From Weight Loss Drugs
Nearly 40% of U.S. adults are now considered obese, a figure that continues to climb despite decades of public health campaigns. But the narrative is shifting. The recent decision by the FDA to request the removal of suicide warnings associated with GLP-1 receptor agonists – drugs like Wegovy and Ozempic – isn’t simply a retraction … Read more